$CARL News
Last published 1d ago
- 1d agoCARLCARLSMED, INC. - EX-99.1Earnings ReleasesForm 8-K - Current report - Item 2.02 Item 9.01
- 1d agoCARLCarlsmed® Reports Third Quarter 2026 Financial Results and Raises Full-Year GuidanceGlobeNewswireThird quarter 2026 revenue of $21.6 million, representing 65% growth year-over-year
- 1d agoCARLCarlsmed Third Quarter 2026 Earnings Conference Call - CARLSMED INCEarnings Call TranscriptsLadies and gentlemen, thank you for standing by, and welcome to the Carlsmed Third Quarter 2026 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there
- 2w agoCARLCarlsmed, Inc. to Report Third Quarter 2026 Financial Results on November 10, 2026GlobeNewswireCARLSBAD, Calif., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (NASDAQ:CARL) ("Carlsmed" or the "Company"), a medical technology company pioneering AI-enabled personalized spine surgery solutions,
- 4w agoCARLCarlsmed Launches aprevo® Lumbar Bi-lateral Posterior SystemGlobeNewswireCARLSBAD, Calif., Oct. 14, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (NASDAQ:CARL) ("Carlsmed" or the "Company"), today announced the U.S. commercial launch of its aprevo® Lumbar Bi-lateral Posterior
- 1mo agoCARLCarlsmed, Inc. Files Patent Infringement Lawsuit against DeGen MedicalGlobeNewswireCARLSBAD, Calif., Sept. 15, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (NASDAQ:CARL) ("Carlsmed" ), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today filed a patent
- 2mo agoCARLCarlsmed, Inc. Announces Chief Operating Officer AppointmentGlobeNewswireCARLSBAD, Calif., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (NASDAQ:CARL) ("Carlsmed" or the "Company"), a medical technology company pioneering AI-enabled personalized spine surgery solutions,
- 3mo agoCARL2026 SMID CAP EXECUTIVE INSIGHTS EVENT (VIRTUAL) - CARLSMED INCEarnings Call TranscriptsHi, everyone. Thanks for joining. I just wanted to come on to say welcome. Thanks for joining one of the sessions of day two of our Small and Mid-Cap virtual event. Great opportunity to hear from corporates across the Sm
- 3mo agoCARLCarlsmed® Reports Second Quarter 2026 Financial Results and Raises Full-Year GuidanceGlobeNewswireSecond quarter 2026 revenue of $18.9 million, representing 57% growth year-over-year Full year 2026 revenue guidance raised to $74 million to $78 million CARLSBAD, Calif., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Carlsmed,
- 3mo agoCARLCarlsmed Announces Favorable Reimbursement for aprevo® lumbar ProceduresGlobeNewswireCARLSBAD, Calif., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (NASDAQ:CARL) ("Carlsmed" or the "Company"), a medical technology company pioneering AI-enabled personalized spine surgery solutions,
- 3mo agoCARLCarlsmed, Inc. To Participate in Upcoming Investor ConferencesGlobeNewswireCARLSBAD, Calif., July 27, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (NASDAQ:CARL) ("Carlsmed" or the "Company"), a medical technology company pioneering AI-enabled personalized spine surgery solutions
- 3mo agoCARLCarlsmed Inc. to Report Second Quarter 2026 Financial Results on August 5, 2026GlobeNewswireCARLSBAD, Calif., July 22, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (NASDAQ:CARL) ("Carlsmed" or the "Company"), a medical technology company pioneering AI-enabled personalized spine surgery solutions,
- 4mo agoCARLLunch Panel - Keeping an AI on MedTech: Learning How AI is Creating Value in The Space – Learnings From CARL, BFLY, IRTC - CARLSMED INCEarnings Call TranscriptsThanks for everyone for joining us. This is, I think, going to be a really insightful panel on the topic we all throw around and the buzzword AI. The title of the panel is Learning How AI is Creating Value in the Space,
- 6mo agoCARL2026 GLOBAL HEALTHCARE CONFERENCE - CARLSMED INCEarnings Call TranscriptsCan you just take the opportunity to go through maybe an introduction of the company and what are some key long-term growth drivers? Yeah, I would love to. So, co-founded Carl's Med in 2018, really with the mission to im
- 6mo agoCARLCarlsmed First Quarter 2026 Earnings Conference Call - CARLSMED INCEarnings Call TranscriptsLadies and gentlemen, thank you for standing by, and welcome to the CARLS-MED first quarter 2026 earnings conference call. At this time, all participants are in the listening-only mode. After the speaker's presentation,
- 6mo agoCARLCarlsmed® Reports First Quarter 2026 Financial ResultsGlobeNewswireFirst quarter 2026 revenue of $16.1 million, representing 58% growth year-over-year Full year 2026 revenue guidance raised to $72 million to $77 million CARLSBAD, Calif., May 05, 2026 (GLOBE NEWSWIRE) -- Carlsmed,
- 6mo agoCARLCarlsmed, Inc. To Participate in Upcoming Investor ConferencesGlobeNewswireCARLSBAD, Calif., April 28, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (NASDAQ:CARL) ("Carlsmed" or the "Company"), today announced that Mike Cordonnier, Chairman and Chief Executive Officer, will participate in the
- 7mo agoCARLCarlsmed Inc. to Report First Quarter 2026 Financial Results on May 5, 2026GlobeNewswireCARLSBAD, Calif., April 14, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (NASDAQ:CARL), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced it will report its first
- 7mo agoCARLCarlsmed, Inc. To Participate in the 25th Annual Needham Virtual ConferenceGlobeNewswireCARLSBAD, Calif., April 01, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (NASDAQ:CARL) ("Carlsmed" or the "Company"), today announced that Mike Cordonnier, CEO and Chairman, will be presenting at the 25th Annual Needham
- 8mo agoCARLCARLSMED FOURTH QUARTER 2025 EARNINGS CONFERENCE CALLCARLSMED INCEarnings Call TranscriptsLadies and gentlemen, thank you for standing by, and welcome to the Carls Med fourth quarter and full year 2025 earnings conference call. At this time, all participants are in a listen-only mode. After the speaker's pres
- 8mo agoCARLCarlsmed® Reports Fourth Quarter and Full Year 2025 Financial ResultsGlobeNewswireFourth quarter revenue of $15.2 million; 61% growth YoY Full year revenue of $50.5 million; 86% growth YoY CARLSBAD, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (NASDAQ:CARL) ("Carlsmed" or the
- 8mo agoCARLCarlsmed, Inc. To Participate in the 2026 Canaccord Genuity Musculoskeletal ConferenceGlobeNewswireCARLSBAD, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (NASDAQ:CARL) ("Carlsmed" or the "Company"), today announced that Mike Cordonnier, CEO and Chairman, will be presenting at the 2026 Canaccord Genuity
- 8mo agoCARLCarlsmed Announces first corra™ personalized Cervical Plating ProcedureGlobeNewswireCARLSBAD, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (NASDAQ:CARL) ("Carlsmed" or the "Company"), today announced the first personalized cervical plating procedure using the corra™ Cervical Plating
- 9mo agoCARLCarlsmed Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026GlobeNewswireCARLSBAD, Calif., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (NASDAQ:CARL), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced it will report its fourth
- 9mo agoCARLCarlsmed Announces First aprevo® Bi-lateral Posterior Lumbar Interbody Fusion ProcedureGlobeNewswireCARLSBAD, Calif., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (NASDAQ:CARL) ("Carlsmed" or the "Company"), today announced the successful completion of the first posterior lumbar spine surgery using the Company's
- 10mo agoCARLCarlsmed Announces Preliminary Revenue for the Fourth Quarter and Full Year 2025GlobeNewswireFourth quarter 2025 revenue of ~$15.2 million, representing ~61% growth over Q4 2024Full Year 2025 revenue of ~$50.5 million; representing ~86% growth over 2024 CARLSBAD, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) --
- 10mo agoCARLCarlsmed aprevo® Lumbar 2-year Data Published in Global Spine JournalGlobeNewswireCARLSBAD, Calif., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (NASDAQ:CARL) ("Carlsmed" or the "Company"), today announced the publication of a new retrospective cohort study in Global Spine Journal demonstrating
- 11mo agoCARLCarlsmed, Inc. To Participate in the J.P. Morgan 2026 Healthcare ConferenceGlobeNewswireCARLSBAD, Calif., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (NASDAQ:CARL) ("Carlsmed" or the "Company"), today announced that Mike Cordonnier, Chairman and CEO of Carlsmed will be presenting at the J.P. Morgan
- 11mo agoCARLCarlsmed Announces U.S. Launch of its aprevo® Technology Platform for Cervical Fusion Surgeries at the Cervical Spine Research Society (CSRS) 53rd Annual MeetingGlobeNewswireCARLSBAD, Calif., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (NASDAQ:CARL) ("Carlsmed" or the "Company"), today announced the U.S. commercial launch of its aprevo® Technology Platform for cervical fusion
- 11mo agoCARLCarlsmed, Inc. To Participate in the Piper Sandler 37th Annual Healthcare ConferenceGlobeNewswireCARLSBAD, Calif., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (NASDAQ:CARL) ("Carlsmed" or the "Company"), today announced that Mike Cordonnier, Chairman and CEO of Carlsmed, will be presenting at the 37th Annual
- 1y agoCARLCarlsmed Reports Third Quarter 2025 Financial Results and Raises Full-Year GuidanceGlobeNewswireThird quarter revenue of $13.1 million, representing 98% growth YoY Raising full year 2025 revenue guidance to $49 million - $50 million CARLSBAD, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc.
- 1y agoCARLCarlsmed Inc. to Report Third Quarter 2025 Financial Results on November 6, 2025GlobeNewswireCARLSBAD, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (NASDAQ:CARL), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced it will report its third
- 1y agoCARLCarlsmed, Inc. Appoints Jennifer Kamocsay as Chief Legal Officer and SecretaryGlobeNewswireCARLSBAD, Calif., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc.
- 1y agoCARLCarlsmed, Inc. Selected for Inclusion in Russell 2000® IndexGlobeNewswireCARLSBAD, Calif., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (NASDAQ:CARL) ("Carlsmed" or the "Company"), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced
- 1y agoCARLUPDATE - Carlsmed® Reports Second Quarter 2025 Financial ResultsGlobeNewswireQ2'25 revenue of $12.1 million, 99% YOY growth Full year revenue guidance of $45.5M - $47.5M CARLSBAD, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (NASDAQ:CARL) ("Carlsmed" or the
- 1y agoCARLCarlsmed® Reports Second Quarter 2025 Financial ResultsGlobeNewswireQ2'25 revenue of $12.1 million, 99% YOY growth Full year revenue guidance of $45.5M - $47.5M CARLSBAD, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (NASDAQ:CARL) ("Carlsmed" or the "Company"), a medical
- 1y agoCARLCarlsmed Inc. to Report Second Quarter 2025 Financial Results on August 28, 2025GlobeNewswireCARLSBAD, Calif., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (NASDAQ:CARL), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced it will report its second
- 1y agoCARLCarlsmed's aprevo® Personalized Interbody Implants Receive CMS New Technology Add-On Payment (NTAP) for Cervical Fusion ProceduresGlobeNewswireCARLSBAD, Calif., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc. ("Carlsmed"), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced that in the Hospital Inpatient
- 1y agoCARLCarlsmed's aprevo® Powers First Personalized Cervical Spine SurgeryGlobeNewswireCARLSBAD, Calif., July 28, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (NASDAQ:CARL) ("Carlsmed"), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced the successful
- 1y agoCARLCarlsmed Announces Pricing of Initial Public OfferingBusiness WireCarlsmed, Inc. ("Carlsmed"), a commercial-stage medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced the pricing of its initial public offering of 6,700,000 shares of
- 1y agoCARLCarlsmed Announces Launch of Initial Public OfferingBusiness WireCarlsmed, Inc. ("Carlsmed"), a commercial-stage medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced the launch of its initial public offering of 6,700,000 shares of